▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3710 by analyst upside · 2026-09-27
CYH
Community Health Systems, Inc.
Healthcare · Market Cap $415M · P/E 1.7x
ANALYST PRICE TARGET
+7.4%
implied upside to consensus target
Current Price $2.94
Consensus Target $3.16
Bull Target $4.0
Bear Target $2.0
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
1
Hold
4
Sell
2
52-Week Low $2.41
52-Week High $4.43
YTD Return -5.2%
FUNDAMENTALS
Market Cap $415M
P/E Ratio (TTM) 1.7x
Forward P/E N/A
EPS (TTM) $1.77
PEG Ratio 2.38
Dividend Yield N/A
Revenue (TTM) $12.0B
Profit Margin 2.1%
52-WEEK RANGE
52-Week Low $2.41
52-Week High $4.43
Current Price $2.94
Bear Target $2.0
Bull Target $4.0
● Now $2.94 ● Target $3.16
TRADING DATA
Avg Volume 1.6M
YTD Return -5.2%
Analyst Count 8
Consensus Hold
Upside to Target +7.4%
Last Updated 2026-09-27

ANALYST SUMMARY

Community Health Systems, Inc. (CYH) is currently trading at $2.94 with a Wall Street consensus price target of $3.16, implying potential upside of 7.4% over the next 12 months. 8 analysts currently cover CYH, with a consensus rating of Hold - 25% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $4.0, while the most cautious has a target of $2.0.

CYH operates in the Healthcare sector with a market capitalisation of $415M. The stock is down 5.2% year-to-date and is currently trading near the lower end of its 52-week range of $2.41 – $4.43.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

VMD +40.3%
Viemed Healthcare, Inc.
$339M · P/E 24.7x · Buy
INFU +32.4%
InfuSystem Holdings, Inc.
$253M · P/E 31.8x · Buy
KMDA +54.8%
Kamada Ltd.
$503M · P/E 22.9x · Buy
BVS +27.4%
Bioventus Inc.
$943M · P/E 17.7x · Buy
CGEN +93.3%
Compugen Ltd.
$225M · P/E 6.3x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for CYH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BMO Capital ● Initiated
Market Perform 2026-09-23 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-27 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-07-27 Building track record
UBS - Reiterated
Neutral → Neutral 2026-07-25 33% win rate (6 calls)
Barclays - Reiterated
Underweight → Underweight 2026-07-23 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-07-14 Building track record
Barclays ↓ Downgrade
Equal-Weight → Underweight 2026-07-08 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-04-23 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
17/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →